A study for a vaccine against Bilharzia commences at UVRI
Researchers at the Uganda Virus Research Institute (UVRI) are embarking on a study that could bring to life Uganda’s first vaccine against schistosomiasis, or bilharzia. Dr. Moses Egesa a researcher based in the MRC/UVRI research unit said in an interview on Monday that they will be infecting healthy volunteers with the bilharzia-causing worm to develop…